Neutropenic fever occurs in approximately 30% of cancer patients receiving chemotherapy. It affects more than 60,000 patients annually in the United States. In several studies, the mortality rate of febrile neutropenia is reported from 5.4% to 15%. First-line treatment options for febrile neutropeni